Vedolizumab (Q1537390): Difference between revisions
(Changed label, description and/or aliases in en, pl, and other parts: Updating entity Vedolizumab with Lapacz) |
(Changed an Item: Updating statements of entity ["Vedolizumab" (pl)] with Lapacz) |
||
| Property / Version | |||
| Property / Version: Keira Metz / rank | |||
| Property / National Library Identifier | |||
a1000001046150 | |||
| Property / National Library Identifier: a1000001046150 / rank | |||
Normal rank | |||
| Property / Related Subject | |||
| Property / Related Subject: Przeciwciała monoklonalne / rank | |||
Normal rank | |||
| Property / Related Subject | |||
| Property / Related Subject: Choroba Leśniowskiego-Crohna / rank | |||
Normal rank | |||
| Property / Type | |||
| Property / Type: Unknown / rank | |||
Normal rank | |||
| Property / Version | |||
P88693T47661 | |||
| Property / Version: P88693T47661 / rank | |||
Normal rank | |||
Latest revision as of 16:26, 23 December 2023
No description defined
- Wedolizumab
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vedolizumab |
No description defined |
|
Statements
a1000001046150
0 references
P88693T47661
0 references